1. Home
  2. KRYS vs VMI Comparison

KRYS vs VMI Comparison

Compare KRYS & VMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$279.67

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Logo Valmont Industries Inc.

VMI

Valmont Industries Inc.

HOLD

Current Price

$445.84

Market Cap

8.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
VMI
Founded
2015
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.1B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KRYS
VMI
Price
$279.67
$445.84
Analyst Decision
Strong Buy
Buy
Analyst Count
11
4
Target Price
$257.45
$462.33
AVG Volume (30 Days)
249.5K
117.4K
Earning Date
02-17-2026
02-17-2026
Dividend Yield
N/A
0.57%
EPS Growth
275.72
N/A
EPS
6.66
11.66
Revenue
$373,164,000.00
$4,103,136,000.00
Revenue This Year
$36.10
$1.86
Revenue Next Year
$42.21
$4.12
P/E Ratio
$41.50
$40.78
Revenue Growth
54.51
1.23
52 Week Low
$122.80
$250.07
52 Week High
$295.98
$487.58

Technical Indicators

Market Signals
Indicator
KRYS
VMI
Relative Strength Index (RSI) 55.88 45.61
Support Level $264.85 $463.43
Resistance Level $280.00 $487.58
Average True Range (ATR) 11.47 13.93
MACD -1.66 -1.27
Stochastic Oscillator 49.97 14.40

Price Performance

Historical Comparison
KRYS
VMI

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

Share on Social Networks: